"Dexrazoxane" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The (+)-enantiomorph of razoxane.
| Descriptor ID |
D064730
|
| MeSH Number(s) |
D03.383.606.385.500.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dexrazoxane".
Below are MeSH descriptors whose meaning is more specific than "Dexrazoxane".
This graph shows the total number of publications written about "Dexrazoxane" by people in this website by year, and whether "Dexrazoxane" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dexrazoxane" by people in Profiles.
-
Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children. JAMA Netw Open. 2024 01 02; 7(1):e2351062.
-
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer. J Clin Oncol. 2023 04 20; 41(12):2248-2257.
-
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group. Cancer. 2022 02 15; 128(4):788-796.
-
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Jan; 63(1):54-61.
-
Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group. J Clin Oncol. 2015 Aug 20; 33(24):2639-45.